Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
4
×
bristol-myers squibb
4
×
clinical trials
glaxosmithkline
4
×
life sciences
national
national blog main
national top stories
new york blog main
4
×
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
allergan
cancer
chinook therapeutics
deals
duchenne muscular dystrophy
gene therapy
What
bio
4
×
roundup
cancer
days
drugs
advanced
alliance
appetite
arrival
august
award
biotech
black
bread
bristol
busy
butter
buy
buyout
calls
cash
changing
color
crispr
data
death
decades
decisions
dems
devices
diabetes
diamond’s
drug
eli
fda
giant
given
grabbed
growing
hasn’t
Language
unset
Current search:
glaxosmithkline
×
bio
×
" bristol-myers squibb "
×
" new york blog main "
×
amgen
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More